Third Rock Ventures V, L.P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$17.18M

Insider Activity of Third Rock Ventures V, L.P.

According to the SEC Form 4 filings, Third Rock Ventures V, L.P., being in a position of

  1. 10 percent owner at Rapport Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 0 shares, and sold 854708 shares for $34.39M,
    over all time since 2026-04-17, has bought 0 shares, and sold 854708 shares for $34.39M.

Biography of Third Rock Ventures V, L.P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$41,791,0846100

Comparison of Insiders on Amount of Buys and Sells

2026-08-12SaleSepterna Inc
SEPN
10 percent owner
147,200
0.3407%
$50.27$7.4M-19.31%
2026-05-26SaleRapport Therapeutics, Inc. Common Stock
RAPP
10 percent owner
18,572
0.0516%
$40.05$743,753+0.64%
2026-05-11SaleRapport Therapeutics, Inc. Common Stock
RAPP
10 percent owner
133,618
0.3834%
$40.24$5.38M+2.8%
2026-05-08SaleRapport Therapeutics, Inc. Common Stock
RAPP
10 percent owner
5,018
0.0146%
$40.31$202,256+3.84%
2026-05-07SaleRapport Therapeutics, Inc. Common Stock
RAPP
10 percent owner
271,495
0.7474%
$40.12$10.89M-1.09%
2026-04-17SaleRapport Therapeutics, Inc. Common Stock
RAPP
10 percent owner
426,005
1.1851%
$40.32$17.18M-2.97%
Total: 6
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.